37%28% 29% 23%

28%

25%14%

18%

11%16%

14% 15%

24% 31%43% 44%

0%

25%

50%

75%

100%

Q3 2017 Q4 2017 Q1 2018 Q2 2018

% o

f To

tal D

eals

Quarter & Year

Investment Size (in USD) as % of Total - Biotechs T&D

30m+

15m-30m

5m-15m

<5m

Company Name Sector Amount (in

mUSD)

Type of Round

Financing Stage

Ownership Country

WRIGHT MEDICAL GROUP N.V.

Medical

Technology

675.00 Other Post-IPO Publicly listed

on stock

exchange

Netherlands

FINLESS FOODS INC. Biotechnology -

other

3.50 Other Equity

(private)

Private /

independent

USA

GALMED

PHARMACEUTICALS

LTD.

Biotechnology -

Therapeutics and

Diagnostics

75.00 Other Post-IPO Publicly listed

on stock

exchange

Israel

ADORX

THERAPEUTICS

Biotechnology -

Therapeutics and

Diagnostics

10.00 Series A /

1. Round

Other Private /

independent

United

Kingdom

FULLIFE

HEALTHCARE

Pharma 2.20 Other Other Private /

independent

India

MERCATOR

MEDSYSTEMS INC.

Medical

Technology

11.00 Series D /

4. Round

Equity

(private)

Private /

independent

USA

TILOS

THERAPEUTICS, INC.

Biotechnology -

Therapeutics and

Diagnostics

3.10 Other Equity

(private)

Private /

independent

USA

DECIBEL

THERAPEUTICS INC.

Biotechnology -

Therapeutics and

Diagnostics

55.00 Series C /

3. Round

Other Private /

independent

USA

FREELINE

THERAPEUTICS

Biotechnology -

Therapeutics and

Diagnostics

116.87 Series B /

2. Round

Other Private /

independent

United

Kingdom

CEREBRAL

THERAPEUTICS, LLC.

Biotechnology -

Therapeutics and

Diagnostics

3.00 Series A /

1. Round

Equity

(private)

Private /

independent

USA

EIDOS

THERAPEUTICS INC.

Biotechnology -

Therapeutics and

Diagnostics

106.00 Other IPO Publicly listed

on stock

exchange

USA

iTeos Therapeutics

SA

Biotechnology -

Therapeutics and

Diagnostics

75.00 Series B /

2. Round

Other Private /

independent

Belgium

EMULATE INC. Biotechnology /

R&D Services

36.00 Series C /

3. Round

Other Private /

independent

USA

MICRIMA LIMITED Medical

Technology

5.82 Series A /

1. Round

Other Private /

independent

United

Kingdom

NEUROMETRIX, INC. Medical

Technology

3.80 Other Other Publicly listed

on stock

exchange

USA

ZIPLINE MEDICAL,

INC.

Medical

Technology

9.00 Other UD Private /

independent

USA

VERRICA

PHARMACEUTICALS

INC

Biotechnology -

Therapeutics and

Diagnostics

86.30 UD IPO Publicly listed

on stock

exchange

USA

Alpha Biopharma Biotechnology -

Therapeutics and

Diagnostics

37.00 Series A /

1. Round

UD Private /

independent

China

(Mainland)

ACUTUS MEDICAL,

INC.

Medical

Technology

22.80 Other Debt

financing

Private /

independent

USA

ELUCIDATA

CORPORATION

Biotechnology /

R&D Services

1.70 Other Equity

(private)

Private /

independent

USA

WINDMIL

THERAPEUTICS INC.

Biotechnology -

Therapeutics and

Diagnostics

32.50 Series B /

2. Round

Equity

(private)

Private /

independent

USA

HAEMONETICS

CORPORATION

Medical

Technology

700.00 Other Debt

financing

Publicly listed

on stock

exchange

USA

STEALTH

BIOTHERAPEUTICS

INC.

Biotechnology -

Therapeutics and

Diagnostics

100.00 Other UD Private /

independent

USA

ACHIEVE LIFE

SCIENCES, INC.

Biotechnology -

Therapeutics and

Diagnostics

12.00 Other Post-IPO Publicly listed

on stock

exchange

USA

AMAG

PHARMACEUTICALS,

INC.

Pharma 530.00 Other Other Publicly listed

on stock

exchange

USA

ThinkCyte Inc Biotechnology /

R&D Services

3.20 Other Equity

(private)

Private /

independent

Japan

STRIDEBIO, INC. Biotechnology -

Therapeutics and

Diagnostics

15.70 Series A /

1. Round

Other Private /

independent

USA

ARCADIA

BIOSCIENCES, INC.

Biotechnology -

other

13.83 Other Post-IPO Publicly listed

on stock

exchange

USA

SAGE

THERAPEUTICS

Biotechnology -

Therapeutics and

Diagnostics

575.00 Other Other Publicly listed

on stock

exchange

USA

BENCHLING, INC. Biotechnology /

R&D Services

14.50 Series B /

2. Round

Other Private /

independent

USA

Medrobotics

Corporation

Medical

Technology

25.00 Other UD Private /

independent

USA

MIALGAE Biotechnology -

other

0.66 Series A /

1. Round

Equity

(private)

Private /

independent

United

Kingdom

REATA

PHARMACEUTICALS,

INC.

Biotechnology -

Therapeutics and

Diagnostics

125.00 Other Other Publicly listed

on stock

exchange

USA

EPIVAX ONCOLOGY

INC.

Biotechnology -

Therapeutics and

Diagnostics

1.20 Other Other Private /

independent

USA

TROPIC

BIOSCIENCES UK

LTD

Biotechnology -

other

10.00 Series A /

1. Round

Other Private /

independent

United

Kingdom

EVOLVE

BIOSYSTEMS, INC.

Biotechnology -

other

40.00 Series C /

3. Round

Other Private /

independent

USA

KADMON

HOLDINGS, INC.

Pharma 100.00 Other Other Publicly listed

on stock

exchange

USA

RA MEDICAL

SYSTEMS, INC.

Medical

Technology

18.30 Other Other Private /

independent

USA

SUPIRA MEDICAL Medical

Technology

15.50 Series A /

1. Round

Equity

(private)

Private /

independent

USA

INSPHERO AG Biotechnology /

R&D Services

10.00 Other Other Private /

independent

Switzerland

REGENXBIO INC. Biotechnology -

Therapeutics and

Diagnostics

100.00 Other Other Publicly listed

on stock

exchange

USA

VERGENT

BIOSCIENCE

Biotechnology /

R&D Services

8.70 Series A /

1. Round

Other Private /

independent

USA

XACT ROBOTICS™

LTD.

Medical

Technology

5.00 Other Other Private /

independent

Israel

BRONCUS

TECHNOLOGIES,

INC.

Medical

Technology

15.00 Series A /

1. Round

Equity

(private)

Private /

independent

USA

UPSIDE

BIOTECHNOLOGIES

LTD.

Biotechnology -

Therapeutics and

Diagnostics

1.36 Other Convertible

loan

Private /

independent

New

Zealand

AGEX

THERAPEUTICS, INC.

Biotechnology -

Therapeutics and

Diagnostics

5.00 Other Post-IPO Subsidiary USA

IMMUNOGEN, INC. Biotechnology -

Therapeutics and

Diagnostics

150.70 Other Post-IPO Publicly listed

on stock

exchange

USA

MELINTA

THERAPEUTICS, INC.

Biotechnology -

Therapeutics and

Diagnostics

123.00 Other Post-IPO Publicly listed

on stock

exchange

USA

DECIPHERA

PHARMACEUTICALS,

INC.

Biotechnology -

Therapeutics and

Diagnostics

172.00 Other Other Publicly listed

on stock

exchange

USA

MIRATI

THERAPEUTICS INC.

Biotechnology -

Therapeutics and

Diagnostics

139.20 Other Post-IPO Publicly listed

on stock

exchange

USA

NEURALSTEM, INC. Biotechnology -

Therapeutics and

Diagnostics

0.15 Other Research

grants

Publicly listed

on stock

exchange

USA

AIVITA BIOMEDICAL Medical

Technology

15.00 Series B /

2. Round

Equity

(private)

Private /

independent

USA

ZYMEWORKS INC. Biotechnology -

Therapeutics and

Diagnostics

97.80 Other Post-IPO Publicly listed

on stock

exchange

Canada

OptiNose US Inc. Biotechnology -

Therapeutics and

Diagnostics

60.10 Other Post-IPO Publicly listed

on stock

exchange

USA

RSP SYSTEMS A/S Medical

Technology

7.58 Series B /

2. Round

Equity

(private)

Private /

independent

Denmark

HUMACYTE, INC. Medical

Technology

150.00 Series D /

4. Round

Other Private /

independent

USA

METAFORA

biosystems

Biotechnology /

R&D Services

3.73 UD Research

grants

Private /

independent

France

Cue Health Inc. Medical

Technology

45.00 Series B /

2. Round

Equity

(private)

Private /

independent

USA

ABL Bio,Inc. Biotechnology -

Therapeutics and

Diagnostics

65.00 Series C /

3. Round

UD Private /

independent

South Korea

SUTROVAX, INC. Biotechnology -

Therapeutics and

Diagnostics

85.00 Series C /

3. Round

UD Private /

independent

USA

SIRNAOMICS, INC. Biotechnology -

Therapeutics and

Diagnostics

25.00 Series C /

3. Round

UD Private /

independent

USA

BIOMODEX Medical

Technology

15.00 Series A /

1. Round

Other Private /

independent

France

TAPIMMUNE INC. Biotechnology -

Therapeutics and

Diagnostics

70.00 Other Other Publicly listed

on stock

exchange

USA

PAVMED INC. Medical

Technology

10.40 Other Other Publicly listed

on stock

exchange

USA

PRECISION

BIOSCIENCES, INC.

Biotechnology /

R&D Services

88.10 Series B /

2. Round

Other Private /

independent

USA

Immunovia AB Biotechnology /

R&D Services

36.63 Other Other Publicly listed

on stock

exchange

Sweden

Certa Therapeutics Biotechnology -

Therapeutics and

Diagnostics

18.52 Other Other Private /

independent

Australia

AVITA MEDICAL

EUROPE LTD

Medical

Technology

21.15 Other Other Publicly listed

on stock

exchange

United

Kingdom

BIOMARIN

PHARMACEUTICAL

INC.

Pharma 20.00 Other Other Publicly listed

on stock

exchange

USA

TROVAGENE, INC. Biotechnology -

Therapeutics and

Diagnostics

18.00 Other Other Publicly listed

on stock

exchange

USA

MEIRAGTX

HOLDINGS PLC

Biotechnology -

Therapeutics and

Diagnostics

75.00 Other IPO Publicly listed

on stock

exchange

United

Kingdom

Oncologie, Inc. Biotechnology -

Therapeutics and

Diagnostics

16.50 UD Equity

(private)

Private /

independent

USA

HEAT BIOLOGICS,

INC.

Biotechnology -

Therapeutics and

Diagnostics

20.70 Other Post-IPO Publicly listed

on stock

exchange

USA

METACRINE, INC. Biotechnology -

Therapeutics and

Diagnostics

65.00 Series C /

3. Round

Equity

(private)

Private /

independent

USA

BIOCORRX, INC. Biotechnology -

Therapeutics and

Diagnostics

1.10 Other UD Publicly listed

on stock

exchange

USA

Alkermes plc Pharma 50.00 Other Other Publicly listed

on stock

exchange

Ireland

Orasis

Pharmaceuticals

Biotechnology -

Therapeutics and

Diagnostics

13.00 Series B /

2. Round

Equity

(private)

Private /

independent

Israel

T2 Biosystems, Inc. Biotechnology -

Therapeutics and

Diagnostics

52.60 Other Post-IPO Publicly listed

on stock

exchange

USA

GENETESIS Medical

Technology

7.50 Series A /

1. Round

Equity

(private)

Private /

independent

USA

Oncolytics Biotech

Inc.

Biotechnology -

Therapeutics and

Diagnostics

8.90 Other Post-IPO Publicly listed

on stock

exchange

Canada

VERICEL

CORPORATION

Biotechnology -

Therapeutics and

Diagnostics

74.80 Other Post-IPO Publicly listed

on stock

exchange

USA

Cytrellis Biosystems,

Inc.

Medical

Technology

28.50 Series B /

2. Round

Other Private /

independent

USA

Nimbus

Therapeutics

Biotechnology -

Therapeutics and

Diagnostics

65.00 Other Other Private /

independent

USA

CMR SURGICAL LTD Medical

Technology

116.68 Series B /

2. Round

Other Private /

independent

United

Kingdom

TRICARES SAS Medical

Technology

25.67 Series B /

2. Round

Other Private /

independent

France

ENYO PHARMA SA Biotechnology -

Therapeutics and

Diagnostics

46.67 Series B /

2. Round

Equity

(private)

Private /

independent

France

SESEN BIO Biotechnology -

Therapeutics and

Diagnostics

46.00 Other Post-IPO Publicly listed

on stock

exchange

USA

MEDLEY GENOMICS Biotechnology /

R&D Services

0.30 Other Research

grants

Private /

independent

USA

CLINICAL

GENOMICS

TECHNOLOGIES PTY

LTD.

Biotechnology /

R&D Services

26.00 Other Other Private /

independent

Australia

VERICEL

CORPORATION

Biotechnology -

Therapeutics and

Diagnostics

65.00 UD Other Publicly listed

on stock

exchange

USA

KITOV PHARMA

LTD.

Pharma 8.15 Other Post-IPO Publicly listed

on stock

exchange

Israel

SCREENPOINT

MEDICAL B.V

Medical

Technology

5.02 Series B /

2. Round

Other Private /

independent

Netherlands

CHEMOTARGETS SL Biotechnology /

R&D Services

0.21 Other Government

subvention

Private /

independent

Spain

CHEMOTARGETS SL Biotechnology /

R&D Services

0.04 Other Government

subvention

Private /

independent

Spain